Appalanaidu Sasapu, MD

Medical experts examine differences and similarities in the referral process and treatment protocols for non–BCMA-targeted vs BCMA-targeted bispecific therapies, including aspects like step-up dosing and premedication.

Medical experts address the referral process for bispecific therapy between community and academic centers, including patient eligibility and educational requirements such as REMS certification.

Community and academic oncologists discussed how effective communication between practices can enhance multiple myeloma outcomes.

Medical experts discuss streamlining referrals to reduce treatment delays, optimizing resources, comparing outcomes in collaborative vs noncollaborative settings, and managing patient reluctance about academic center referrals.v

Medical experts highlight the critical role of collaboration between academic and community physicians in managing multiple myeloma, focusing on coordinating care, maintaining communication, and ensuring centers are prepared for patient transitions.